Sarepta Therapeutics (SRPT)

Sarepta Therapeutics (SRPT) Stock Price & Analysis


SRPT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$100.01 - $159.89
Previous Close$121.22
Average Volume (3M)898.04K
Market Cap
Enterprise Value$10.81B
Total Cash (Recent Filing)$1.86B
Total Debt (Recent Filing)$1.36B
Price to Earnings (P/E)-11.8
Nov 01, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.31
Shares Outstanding93,278,902
10 Day Avg. Volume867,018
30 Day Avg. Volume898,041
Standard Deviation0.16
Financial Highlights & Ratios
Price to Book (P/B)15.25
Price to Sales (P/S)43.28
Price to Cash Flow (P/CF)-23.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue11.02
Enterprise Value/Gross Profit15.36
Enterprise Value/Ebitda-14.66
Price Target Upside55.16% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Sarepta Therapeutics’s price range in the past 12 months?
Sarepta Therapeutics lowest stock price was $100.01 and its highest was $159.89 in the past 12 months.
    What is Sarepta Therapeutics’s market cap?
    Currently, no data Available
    When is Sarepta Therapeutics’s upcoming earnings report date?
    Sarepta Therapeutics’s upcoming earnings report date is Nov 01, 2023 which is in 29 days.
      How were Sarepta Therapeutics’s earnings last quarter?
      Sarepta Therapeutics released its earnings results on Aug 02, 2023. The company reported -$0.27 earnings per share for the quarter, beating the consensus estimate of -$1.777 by $1.507.
        Is Sarepta Therapeutics overvalued?
        According to Wall Street analysts Sarepta Therapeutics’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Sarepta Therapeutics pay dividends?
          Sarepta Therapeutics does not currently pay dividends.
          What is Sarepta Therapeutics’s EPS estimate?
          Sarepta Therapeutics’s EPS estimate is -$1.26.
            How many shares outstanding does Sarepta Therapeutics have?
            Sarepta Therapeutics has 93,278,900 shares outstanding.
              What happened to Sarepta Therapeutics’s price movement after its last earnings report?
              Sarepta Therapeutics reported an EPS of -$0.27 in its last earnings report, beating expectations of -$1.777. Following the earnings report the stock price went up 2.053%.
                Which hedge fund is a major shareholder of Sarepta Therapeutics?
                Among the largest hedge funds holding Sarepta Therapeutics’s share is Farallon Capital Management, L.L.C.. It holds Sarepta Therapeutics’s shares valued at 138M.


                  Sarepta Therapeutics Stock Smart Score

                  The Sarepta Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Sarepta Therapeutics

                  Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.


                  Top 5 ETFs holding SRPT

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Vanguard Health Care ETF
                  Vanguard Russell 1000 Growth ETF
                  Vanguard Russell 1000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold SRPT. The ETFs are listed according to market value of SRPT within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  BioMarin Pharmaceutical
                  Ionis Pharmaceuticals
                  Ultragenyx Pharmaceutical
                  Bluebird Bio

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis